Recombinant Human VEGF 121 (aa 207-327) Protein

Citations are publications that use Bio-Techne products. Selected citations for Recombinant Human VEGF 121 (aa 207-327) Protein include:

• Species: N/A
  Sample Types: Recombinant Protein
  Applications: Western Blot

  Y Ichiyama et al. (2022), Assessment of mouse VEGF neutralization by ranibizumab and aflibercept PLoS ONE, 17(12):e0278951.
  PMID:  36542626
• Species: Human
  Sample Types: Cell Culture Supernates
  Applications: ELISA Capture

  L Martin et al. (2021), VEGF counteracts amyloid-&beta-induced synaptic dysfunction Cell Reports, 35(6):109121.
  PMID:  33979625
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  S Ma et al. (2021), CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance Cell Reports, 36(7):109549.
  PMID:  34407412
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  F Njau et al. (2020), Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice PLoS ONE, 15(1):e0218494.
  PMID:  31935212
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  C Abou Fayca et al. (2019), A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells Sci Rep, 9(1):336.
  PMID:  30674935
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  S Stephenson et al. (2019), Growth Factor-like Gene Regulation Is Separable from Survival and Maturation in Antibody-Secreting Cells J. Immunol., 202(4):1287-1300.
  PMID:  30642980
• Species: Human
  Sample Types: Recombinant Protein
  Applications: Bioassay

  Ö Uslu et al. (2019), VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization Cells, 8(11).
  PMID:  31698750
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  S Kapur et al. (2017), Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis Bioeng Transl Med, 2(1):81-91.
  PMID:  28516164
• 
  
  Applications: Western Blot

  N Patel et al. (2017), Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab EJNMMI Res, 7(1):49.
  PMID:  28560583
• Species: Hamster
  Sample Types: Whole Cells
  Applications: Bioassay

  Ahmadova Z et al. (2014), Fluorescent resonance energy transfer imaging of VEGFR dimerization. Anticancer Res, 34(5):2123-33.
  PMID:  24778014
• 
  
  

  Chen P et al. (2014), The docking protein FRS2alpha is a critical regulator of VEGF receptors signaling. Proc Natl Acad Sci U S A, 111(15):5514-9.
  PMID:  24706887
• Species: Mouse
  Sample Types: Whole Tissue
  Applications: Bioassay

  Esquibies A et al. (2014), Heparin binding VEGF isoforms attenuate hyperoxic embryonic lung growth retardation via a FLK1-neuropilin-1-PKC dependent pathway. Respir Res, 15(0):32.
  PMID:  24641672
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  Tannetta D et al. (2013), Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS ONE, 8(2):e56754.
  PMID:  23437230
• Species: Human
  Sample Types: Recombinant Protein
  Applications: Surface Plasmon Resonance

  Martino MM et al. (2010), The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J., 24(12):4711-21.
  PMID:  20671107
• Species: Human
  Sample Types: Whole Cells
  Applications: Bioassay

  Rennel ES et al. (2009), VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer, 101(7):1183-93.
  PMID:  19707198

There are no citations that match your criteria.

Customer Images

• 
• (1)

• Name: Anonymous
  Application: SDS-PAGE Control
  Verified Customer | Posted 12/20/2017
  

There are no reviews that match your criteria.